首页> 外文期刊>Molecular cancer therapeutics >Antimigratory effect of TK1-2 is mediated in part by interfering with integrin alpha2beta1.
【24h】

Antimigratory effect of TK1-2 is mediated in part by interfering with integrin alpha2beta1.

机译:TK1-2的抗迁移作用部分是通过干扰整联蛋白alpha2beta1来介导的。

获取原文
获取原文并翻译 | 示例
           

摘要

The recombinant two kringle domain of human tissue-type plasminogen activator (TK1-2) has been shown to inhibit endothelial cell proliferation, angiogenesis, and tumor cell growth despite of sharing a low amino acid sequence homology with angiostatin. Here, we explored a possible inhibitory mechanism of action of TK1-2 by focusing on antimigratory effect. TK1-2 effectively inhibited endothelial cell migration induced by basic fibroblast growth factor or vascular endothelial growth factor in a dose-dependent manner and tube formation on Matrigel. It blocked basic fibroblast growth factor-induced or vascular endothelial growth factor-induced phosphorylation of extracellular signal-regulated kinase 1/2 and formation of actin stress fibers and focal adhesions. Interestingly, TK1-2 alone induced the weak phosphorylation of focal adhesion kinase, whereas it inhibited focal adhesion kinase phosphorylation induced by growth factors. When immobilized, TK1-2 promoted adhesion and spreading of endothelial cells compared with bovine serum albumin. However, treatment with anti-alpha(2)beta(1) blocking antibody markedly diminished endothelial cell adhesion to immobilized TK1-2 compared with anti-alpha(v)beta(3) or anti-alpha(5)beta(1) antibody. Pretreatment of soluble TK1-2 also altered the binding level of anti-alpha(2)beta(1) antibody to endothelial cells in fluorescence-activated cell sorting analysis. Indeed, a blocking antibody against integrin alpha(2)beta(1) or knocking down of integrin alpha(2) expression prevented the inhibitory effect of TK1-2 in cell migration. Therefore, these results suggest that TK1-2 inhibits endothelial cell migration through inhibition of signaling and cytoskeleton rearrangement in part by interfering with integrin alpha(2)beta(1).
机译:尽管与血管抑素的氨基酸序列同源性较低,但已证明重组的人组织型纤溶酶原激活物(TK1-2)的两个kringle域可抑制内皮细胞增殖,血管生成和肿瘤细胞生长。在这里,我们重点研究了抗迁移作用,探讨了TK1-2可能的抑制作用机制。 TK1-2以剂量依赖的方式有效抑制了碱性成纤维细胞生长因子或血管内皮生长因子诱导的内皮细胞迁移,并在基质胶上形成了管。它阻止了碱性成纤维细胞生长因子诱导的或血管内皮生长因子诱导的细胞外信号调节激酶1/2的磷酸化以及肌动蛋白应激纤维和粘着斑的形成。有趣的是,TK1-2单独诱导了粘着斑激酶的弱磷酸化,而它却抑制了生长因子诱导的粘着斑激酶的磷酸化。固定后,与牛血清白蛋白相比,TK1-2促进内皮细胞的粘附和扩散。但是,与抗alpha(v)beta(3)或抗alpha(5)beta(1)抗体相比,使用抗alpha(2)beta(1)阻断抗体治疗可显着减少内皮细胞对固定化TK1-2的粘附。在荧光激活的细胞分选分析中,可溶性TK1-2的预处理还改变了抗alpha(2)beta(1)抗体与内皮细胞的结合水平。实际上,针对整联蛋白α(2)β(1)的封闭抗体或敲低整联蛋白α(2)的表达阻止了TK1-2在细胞迁移中的抑制作用。因此,这些结果表明TK1-2部分通过干扰整联蛋白alpha(2)beta(1)来抑制信号传导和细胞骨架重排,从而抑制内皮细胞迁移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号